Literature DB >> 9846603

Protein trafficking in malaria-infected erythrocytes.

M Foley1, L Tilley.   

Abstract

The malaria parasite invades the human erythrocyte and converts this simple "sack of haemoglobin" back into a functional eukaryotic cell. Parasite-encoded proteins are trafficked to the red blood cell membrane where they modify its properties to meet the needs of the intracellular parasite. Trafficking of proteins within the parasite probably occurs via a "classical" vesicle-mediated secretory pathway; however, the transit of proteins from the parasite plasma membrane to the erythrocyte membrane appears to involve both a novel vesicle-mediated pathway and a direct protein-translocation system. The polypeptide signals that direct parasite proteins into these novel export pathways may include an unusual "internal" hydrophobic sequence, as well as a series of basic motifs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846603     DOI: 10.1016/s0020-7519(98)00132-5

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  4 in total

1.  Structure of Plasmodium falciparum ADP-ribosylation factor 1.

Authors:  William J Cook; Craig D Smith; Olga Senkovich; Anthony A Holder; Debasish Chattopadhyay
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-27

2.  Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway.

Authors:  R F Waller; M B Reed; A F Cowman; G I McFadden
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

Review 3.  Chaperoning of asparagine repeat-containing proteins in Plasmodium falciparum.

Authors:  Thavamani Rajapandi
Journal:  J Parasit Dis       Date:  2020-07-25

4.  Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malaria.

Authors:  Karan Uppal; Jorge L Salinas; Wuelton M Monteiro; Fernando Val; Regina J Cordy; Ken Liu; Gisely C Melo; Andre M Siqueira; Belisa Magalhaes; Mary R Galinski; Marcus V G Lacerda; Dean P Jones
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.